World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
99
Citations
35602
World Ranking
8605
National Ranking
4435

Alberto S. Pappo publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Alberto S. Pappo sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 434 publications — 46th percentile

46% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Alberto S. Pappo D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Alberto S. Pappo sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 99 D-Index — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Alberto S. Pappo is affiliated with St. Jude Children's Research Hospital in the United States. Their research spans several interconnected fields within medicine, with a strong focus on oncology, molecular biology, and cancer research. They have contributed extensively to topics such as sarcoma diagnosis and treatment, CAR-T cell therapy, neuroblastoma research, cancer genomics and diagnostics, tumor oncology, cutaneous melanoma management, and the quality of life of childhood cancer survivors.

The main research areas covered by Pappo include:

  • Pulmonary and Respiratory Medicine
  • Oncology
  • Molecular Biology
  • Surgery
  • Cancer Research

Their work addresses multiple specific topics, including:

  • Sarcoma Diagnosis and Treatment
  • CAR-T cell therapy research
  • Neuroblastoma Research and Treatments
  • Cancer Genomics and Diagnostics
  • Tumors and Oncological Cases
  • Cutaneous Melanoma Detection and Management
  • Childhood Cancer Survivors' Quality of Life

Pappo has contributed to a number of scientific papers, including:

  • Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology (2022), Journal of the National Comprehensive Cancer Network
  • Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials (2020), The Lancet Oncology
  • NCCN Guidelines Insights: Soft Tissue Sarcoma, Version 1.2021 (2020), Journal of the National Comprehensive Cancer Network
  • St. Jude Cloud: A Pediatric Cancer Genomic Data-Sharing Ecosystem (2021), Cancer Discovery
  • MYCN amplification and ATRX mutations are incompatible in neuroblastoma (2020), Nature Communications

Their frequent co-authors include:

  • Sara M. Federico
  • Matthew J. Krasin
  • Armita Bahrami
  • Karsten Nysom
  • Gilles Vassal

Pappo's work has been regularly published in several key venues, highlighting their engagement with the academic community in oncology and related specialties. The most frequent publication venues are:

  • Faculty Opinions - Post-Publication Peer Review of the Biomedical Literature
  • Journal of Clinical Oncology
  • European Journal of Cancer
  • Pediatric Blood & Cancer
  • Cancer

Best Publications

  • Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children

    Alexander Drilon;Theodore W. Laetsch;Shivaani Kummar;Steven G. DuBois

  • Germline Mutations in Predisposition Genes in Pediatric Cancer

    Jinghui Zhang;Michael F. Walsh;Gang Wu;Michael N. Edmonson

  • NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines.

    George D. Demetri;Robert S. Benjamin;Charles D. Blanke;Jean Yves Blay

  • Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials

    David S Hong;Steven G DuBois;Shivaani Kummar;Anna F Farago

  • Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology

    Margaret von Mehren;R. Lor Randall;Robert S. Benjamin;Sarah Boles

  • Recurrent Somatic Structural Variations Contribute to Tumorigenesis in Pediatric Osteosarcoma

    Xiang Chen;Armita Bahrami;Alberto Pappo;John Easton

  • Prognostic Factors and Clinical Outcomes in Children and Adolescents With Metastatic Rhabdomyosarcoma—A Report From the Intergroup Rhabdomyosarcoma Study IV

    John C. Breneman;Elizabeth Lyden;Alberto S. Pappo;Michael P. Link

  • Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study.

    Theodore W Laetsch;Steven G DuBois;Leo Mascarenhas;Brian Turpin

  • Association of Age at Diagnosis and Genetic Mutations in Patients With Neuroblastoma

    Nai-Kong V. Cheung;Jinghui Zhang;Charles Lu;Matthew Parker

  • Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V.

    R. Raney;James Anderson;Frederic Barr;Sarah Donaldson

  • R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor 1 Receptor, in Patients With Recurrent or Refractory Ewing Sarcoma Family of Tumors: Results of a Phase II Sarcoma Alliance for Research Through Collaboration Study

    Alberto S. Pappo;Shreyaskumar R. Patel;John Crowley;Denise K. Reinke

  • Biology and therapy of pediatric rhabdomyosarcoma.

    A S Pappo;D N Shapiro;W M Crist;H M Maurer

  • Analysis of Prognostic Factors in Patients With Nonmetastatic Rhabdomyosarcoma Treated on Intergroup Rhabdomyosarcoma Studies III and IV: The Children's Oncology Group

    Jane L. Meza;James Anderson;Alberto S. Pappo;William H. Meyer

  • Molecular Subtypes of KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Gastrointestinal Stromal Tumor Clinic.

    Sosipatros A. Boikos;Alberto S. Pappo;J. Keith Killian;Michael P. LaQuaglia

  • Direct Translation of a Protracted Irinotecan Schedule From a Xenograft Model to a Phase I Trial in Children

    Wayne L. Furman;Clinton F. Stewart;Catherine A. Poquette;Charles B. Pratt

  • Targeting Oxidative Stress in Embryonal Rhabdomyosarcoma

    Xiang Chen;Elizabeth Stewart;Anang A. Shelat;Chunxu Qu

  • Survival After Relapse in Children and Adolescents With Rhabdomyosarcoma: A Report From the Intergroup Rhabdomyosarcoma Study Group

    Alberto S. Pappo;James R. Anderson;William M. Crist;Moody D. Wharam

  • The Intergroup Rhabdomyosarcoma Study Group (IRSG): Major Lessons From the IRS-I Through IRS-IV Studies as Background for the Current IRS-V Treatment Protocols.

    R. Beverly Raney;Harold M. Maurer;James R. Anderson;Richard J. Andrassy

  • Pleuropulmonary blastoma: A marker for familial disease

    John R. Priest;Jan Watterson;Louise Strong;Vicki Huff

  • Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1–2 trial

    Birgit Geoerger;Hyoung Jin Kang;Michal Yalon-Oren;Lynley V Marshall

Frequent Co-Authors

Charles B. Pratt
Charles B. Pratt St. Jude Children's Research Hospital
Michael A. Dyer
Michael A. Dyer St. Jude Children's Research Hospital
David M. Parham
David M. Parham Children's Hospital of Los Angeles
Thomas E. Merchant
Thomas E. Merchant St. Jude Children's Research Hospital
James R. Downing
James R. Downing St. Jude Children's Research Hospital
Jinghui Zhang
Jinghui Zhang St. Jude Children's Research Hospital
John Easton
John Easton St. Jude Children's Research Hospital
Sheila A. Shurtleff
Sheila A. Shurtleff St. Jude Children's Research Hospital
Gang Wu
Gang Wu Washington University in St. Louis
Larry E. Kun
Larry E. Kun St. Jude Children's Research Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Medicine in the USA opens doors to numerous related healthcare careers. Students seeking alternatives to traditional pre-med tracks may explore several online degree options that provide strong foundations for healthcare professions.

Nursing remains a highly rewarding path, and some colleges offer an lpn program without teas test, allowing you to begin your nursing journey without the stress of standardized entrance exams. This is ideal for those who want a practical entry point into nursing.

Those interested in the administrative side of healthcare can consider healthcare administration degree programs. These online degrees are designed for individuals looking to manage hospital operations or lead in clinical settings.

For nurses aiming to advance, adn to np bridge programs provide an efficient route from an associate’s degree in nursing to becoming a nurse practitioner. These programs are tailored for working professionals.

Interested in nutrition and public health? An online bs in nutrition offers comprehensive training that prepares graduates for roles in wellness, education, or clinical settings.

Each of these online pathways combines academic flexibility with strong job prospects—making them excellent complements to or alternatives for a traditional medical degree.

Best Scientists Citing Alberto S. Pappo

Trending Scientists

Recently Published Articles